Dolutegravir and neuropsychiatric adverse events: a continuing debate.
Sign Up to like & getrecommendations! Published in 2017 at "AIDS"
DOI: 10.1097/qad.0000000000001596
Abstract: We read with great interest the series of letters regarding dolutegravir-related neuropsychiatric adverse events (NP-AE) [1–4]. We report, here, our experience in a French cohort, to add on the current debate. Data were obtained from… read more here.
Keywords: adverse events; continuing debate; events continuing; neuropsychiatric adverse ... See more keywords
Continuing the debate: Cognitive enhancement therapy for mood disorders
Sign Up to like & getrecommendations! Published in 2020 at "Bipolar Disorders"
DOI: 10.1111/bdi.12919
Abstract: We recently published a debate article on the topic of cognitive interventions for mood disorders (1), which has received interest from experts in the area, including many of our respected colleagues (2, 3). We appreciate,… read more here.
Keywords: disorders continuing; continuing debate; mood disorders; debate cognitive ... See more keywords
FDG uptake in cancer: a continuing debate
Sign Up to like & getrecommendations! Published in 2020 at "Theranostics"
DOI: 10.7150/thno.40599
Abstract: Corresponding authors: Lido Calorini MD, Dipartimento di Scienze Biomediche Sperimentali e Cliniche, Sezione di Patologia e Oncologia Sperimentali, Università di Firenze, Viale G.B. Morgagni, 50, I-50134 Firenze; Phone +39 0552751286; Fax +39 0552758411; e-mail:… read more here.
Keywords: uptake cancer; fdg uptake; continuing debate; firenze ... See more keywords